[Microangiopathic hemolytic anemia associated with breast cancer].
A case of microangiopathic hemolytic anemia associated to metastatic breast cancer, in remission with chemotherapy, is presented. We review the etiopathogenetic mechanism of its association and focus on the priority of neoplasia therapy when disseminated intravascular coagulation is not present.
Burillo Lorente
J
J
Servicio de Medicina Interna, Hospital de Bellvitge, Barcelona.
Lozano Borbalas
A
A
Navarro Echevarría
M A
MA
Pinto Sala
J
J
Sánchez Parra
M
M
Moga Sempere
I
I
D000230:Adenocarcinoma / Q000150:complications* / Q000628:therapy; D000328:Adult; D000743:Anemia, Hemolytic / Q000175:diagnosis / Q000209:etiology*; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000150:complications* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D013997:Time Factors
Anemia hemolítica microangiopática asociada a cáncer de mama.